Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: May 3, 2022
Date Accepted: Sep 30, 2022
Date Submitted to PubMed: Nov 16, 2022

The final, peer-reviewed published version of this preprint can be found here:

Accuracy of COVID-19–Like Illness Diagnoses in Electronic Health Record Data: Retrospective Cohort Study

Rao S, Bozio C, Butterfield K, Reynolds S, Reese S, Ball S, Steffens A, Demarco M, McEvoy C, Thompson M, Rowley E, Porter R, Fink R, Irving S, Naleway A

Accuracy of COVID-19–Like Illness Diagnoses in Electronic Health Record Data: Retrospective Cohort Study

JMIR Form Res 2023;7:e39231

DOI: 10.2196/39231

PMID: 36383633

PMCID: 9848441

Accuracy of COVID-19-Like-Illness Diagnoses in Electronic Health Record Data: Retrospective Cohort Study

  • Suchitra Rao; 
  • Catherine Bozio; 
  • Kristen Butterfield; 
  • Sue Reynolds; 
  • Sarah Reese; 
  • Sarah Ball; 
  • Andrea Steffens; 
  • Maria Demarco; 
  • Charlene McEvoy; 
  • Mark Thompson; 
  • Elizabeth Rowley; 
  • Rachael Porter; 
  • Rebecca Fink; 
  • Stephanie Irving; 
  • Allison Naleway

ABSTRACT

Background:

Electronic health record (EHR) data provide a unique opportunity to study COVID-19 and vaccine effectiveness but require a well-defined computable phenotype of COVID-19-like illness (CLI).

Objective:

We evaluated the performance of diagnostic codes in identifying COVID-19 cases in emergency department/urgent care (ED/UC) and inpatient settings.

Methods:

We conducted a retrospective cohort study using EHR, claims, and laboratory data from four U.S. health systems. Patients aged ≥18 years with an ED/UC or inpatient acute respiratory illness (ARI) encounter and SARS-CoV-2 PCR test during March 2020-March 2021 were included. We evaluated CLI definitions using combinations of ICD codes as follows: COVID-19-specific codes; CLI definition used in VISION network studies (VISION CLI); ARI signs, symptoms and diagnosis codes only; signs and symptoms of ARI only; random forest model definitions. We evaluated sensitivity, specificity, positive (PPV), and negative predictive value (NPV) using a positive test reference standard.

Results:

Among 90,952 hospitalizations and 137,067 ED/UC visits, 5,627 (6.2%) and 9,866 (7.2%) were positive for SARS-CoV-2, respectively. COVID-19-specific codes had high sensitivity (91.6%) and specificity (99.6%) for hospitalized patients. The VISION CLI definition maintained high sensitivity (95.8%) but lowered specificity (45.5%). All CLI definitions had lowered sensitivity for ED/UC encounters. Random forest approaches identified distinct CLI definitions with high performance for hospital encounters and moderate performance for ED/UC encounters.

Conclusions:

COVID-19-specific codes have high sensitivity and specificity for identifying SARS-CoV-2 positivity. Separate combinations of COVID-19-specific codes and ARI codes enhance the utility of CLI definitions for studies using EHR data in hospital and ED/UC settings. Clinical Trial: n/a


 Citation

Please cite as:

Rao S, Bozio C, Butterfield K, Reynolds S, Reese S, Ball S, Steffens A, Demarco M, McEvoy C, Thompson M, Rowley E, Porter R, Fink R, Irving S, Naleway A

Accuracy of COVID-19–Like Illness Diagnoses in Electronic Health Record Data: Retrospective Cohort Study

JMIR Form Res 2023;7:e39231

DOI: 10.2196/39231

PMID: 36383633

PMCID: 9848441

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.

Advertisement